Havilah Resources Ltd (ASX:HAV) technical director Chris Giles updates Proactive Investors on the exploration company's revised North Portia sale agreement.
"For us a big improvement is more cash up-front, so we've already been paid $2 million and a further $4 million is due in July," says Giles.
He adds that the revised deal relieves the company of permitting responsibilities and creates certainty of income, and looking at it on any valuation metric, represents a fair price and a good deal for Havilah.
Meet Clinigen Group PLC, MaxCyte, Cello Health PLC, Oncimmune and Silence Therapeutics PLC at our event, London , 11 July 2019. Register here »